Health Innovators – Fady Malik and Steve Heitner

In this instalment of Health Innovators, EiC Jonah Comstock sits down virtually with Fady Malik, EVP of research and development at Cytokinetics and Steve Heitner, the company’s VP of clinical research.

With the help of a visual aid, Steve and Fady explain the workings of the sarcomere and the mechanisms of action that Cytokinetics’ product line in heart disease, ALS, and other neuromuscular diseases are based on.

They discuss the effect of a damaged sarcomere in hypertrophic cardiomyopathy and how it can be corrected using myocin inhibitors and activators. Also, they get into what goes on behind the scenes at Cytokinetics and how the company puts patients first.

Check out the video to learn more about an innovative company focused on an important array of conditions.